Toxicogenomics in predictive toxicology in drug development

Area of Science:

• Toxicology and pharmacology
• Genomics and bioinformatics

Background:

• Risk assessment in toxicology is crucial for human safety.
• Toxicogenomics offers advanced methods for evaluating chemical and drug safety.
• Emerging technologies are transforming toxicological risk assessment.

Purpose of the Study:

• To provide an overview of toxicogenomics, including its platforms, data interpretation, and regulatory implications.
• To highlight the applications of toxicogenomics in compound classification, mechanistic studies, and biomarker discovery.
• To discuss the potential of toxicogenomics in improving preclinical safety assessments and predicting drug interactions.

Main Methods:

• Review of current toxicogenomics technology platforms.
• Analysis of data interpretation strategies in toxicogenomics.
• Examination of regulatory perspectives on toxicogenomics.
• Case studies of toxicogenomics investigations.

Main Results:

• Toxicogenomics enables precise compound classification and mechanistic toxicity studies.
• It facilitates the discovery of toxicity biomarkers, improving early-stage compound evaluation.
• Toxicogenomics enhances the extrapolation of findings across species, increasing predictability.
• Biomarkers derived from toxicogenomics aid in selecting better clinical candidates.

Conclusions:

• Toxicogenomics accelerates preclinical safety assessments and improves the prediction of toxic liabilities.
• It aids in predicting risk accumulation from drug-drug or drug-disease interactions.
• While interpretation requires caution, toxicogenomics is a powerful tool for modern toxicology.
• This technology enhances the overall efficiency and accuracy of risk assessment processes.